Thrombotic thrombocytopenic purpura: Early and late responders

R. Sarode, J. L. Gottschall, R. H. Aster, J. G. McFarland

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the last decade who were treated with a standard therapeutic plasma exchange (TPE) protocol. Seventy percent of the patients were females. The median age of the patients was 43 years (range: 8-80). Sixty patients (85.7%) had a complete response to TPE therapy. This represented 91% of 66 who received at least one TPE. Ten patients died, two patients died before and two during the first plasma exchange. The median number of TPEs performed was nine (range: 1-85). Thirty-five (58%) out of 60 responded to 3-9 TPEs, and 25 (42%) required 10-34 TPEs for the response. The median total plasma volume exchanged was 28 liters (range: 2.7-250 L) and the mean plasma volumes exchanged during each procedure was 3.2 (SD ± 1.09 L). The patients were classified into early responders (ER) and late responders (LR). LRs had a mean platelet count of 180 x 10 9/L by Day 5, mean LDH of 643 IU/L by Day 7, and required median of seven TPEs. ERs had a mean platelet count of 122 x 10 9/L by Day 5, mean LDH of 885 IU/L by Day 7, and required median of 19 TPEs (P = 0.001). The platelet counts were significantly higher (P = 0.01-0.03) in ERs on Days 1, 3, and 5 as compared to LRs but the LDH did not differ significantly. Seventy-seven percent of LRs had exacerbation of TTP and 18% had relapse as compared to 7% each in ERs. Thirteen patients were in coma/semicoma at presentation. Out of these, six died, making coma a bad prognostic indicator. Five of the seven survivors in coma had received two single-plasma volume exchanges on Day 1. In conclusion, 91% of TTP patients had an excellent response to plasma exchange therapy with FFP. Coma/semicoma appears to be a bad prognostic indicator. LRs needed prolonged treatment with a greater number of patients experiencing exacerbation and relapse of TTP as compared to ERs.

Original languageEnglish (US)
Pages (from-to)102-107
Number of pages6
JournalAmerican Journal of Hematology
Volume54
Issue number2
DOIs
StatePublished - 1997

Fingerprint

Thrombotic Thrombocytopenic Purpura
Plasma Exchange
Coma
Plasma Volume
Platelet Count
Therapeutics
Recurrence
Hemolytic Anemia
Thrombocytopenia
Survivors
Fever
Kidney

Keywords

  • coma
  • microangiopathic hemolytic anemia
  • plasma exchange
  • thrombocytopenia
  • thrombotic thrombocytopenic purpura

ASJC Scopus subject areas

  • Hematology

Cite this

Thrombotic thrombocytopenic purpura : Early and late responders. / Sarode, R.; Gottschall, J. L.; Aster, R. H.; McFarland, J. G.

In: American Journal of Hematology, Vol. 54, No. 2, 1997, p. 102-107.

Research output: Contribution to journalArticle

Sarode, R. ; Gottschall, J. L. ; Aster, R. H. ; McFarland, J. G. / Thrombotic thrombocytopenic purpura : Early and late responders. In: American Journal of Hematology. 1997 ; Vol. 54, No. 2. pp. 102-107.
@article{8939f74c21f549eb9210415b3ec257b8,
title = "Thrombotic thrombocytopenic purpura: Early and late responders",
abstract = "Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the last decade who were treated with a standard therapeutic plasma exchange (TPE) protocol. Seventy percent of the patients were females. The median age of the patients was 43 years (range: 8-80). Sixty patients (85.7{\%}) had a complete response to TPE therapy. This represented 91{\%} of 66 who received at least one TPE. Ten patients died, two patients died before and two during the first plasma exchange. The median number of TPEs performed was nine (range: 1-85). Thirty-five (58{\%}) out of 60 responded to 3-9 TPEs, and 25 (42{\%}) required 10-34 TPEs for the response. The median total plasma volume exchanged was 28 liters (range: 2.7-250 L) and the mean plasma volumes exchanged during each procedure was 3.2 (SD ± 1.09 L). The patients were classified into early responders (ER) and late responders (LR). LRs had a mean platelet count of 180 x 10 9/L by Day 5, mean LDH of 643 IU/L by Day 7, and required median of seven TPEs. ERs had a mean platelet count of 122 x 10 9/L by Day 5, mean LDH of 885 IU/L by Day 7, and required median of 19 TPEs (P = 0.001). The platelet counts were significantly higher (P = 0.01-0.03) in ERs on Days 1, 3, and 5 as compared to LRs but the LDH did not differ significantly. Seventy-seven percent of LRs had exacerbation of TTP and 18{\%} had relapse as compared to 7{\%} each in ERs. Thirteen patients were in coma/semicoma at presentation. Out of these, six died, making coma a bad prognostic indicator. Five of the seven survivors in coma had received two single-plasma volume exchanges on Day 1. In conclusion, 91{\%} of TTP patients had an excellent response to plasma exchange therapy with FFP. Coma/semicoma appears to be a bad prognostic indicator. LRs needed prolonged treatment with a greater number of patients experiencing exacerbation and relapse of TTP as compared to ERs.",
keywords = "coma, microangiopathic hemolytic anemia, plasma exchange, thrombocytopenia, thrombotic thrombocytopenic purpura",
author = "R. Sarode and Gottschall, {J. L.} and Aster, {R. H.} and McFarland, {J. G.}",
year = "1997",
doi = "10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0",
language = "English (US)",
volume = "54",
pages = "102--107",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Thrombotic thrombocytopenic purpura

T2 - Early and late responders

AU - Sarode, R.

AU - Gottschall, J. L.

AU - Aster, R. H.

AU - McFarland, J. G.

PY - 1997

Y1 - 1997

N2 - Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the last decade who were treated with a standard therapeutic plasma exchange (TPE) protocol. Seventy percent of the patients were females. The median age of the patients was 43 years (range: 8-80). Sixty patients (85.7%) had a complete response to TPE therapy. This represented 91% of 66 who received at least one TPE. Ten patients died, two patients died before and two during the first plasma exchange. The median number of TPEs performed was nine (range: 1-85). Thirty-five (58%) out of 60 responded to 3-9 TPEs, and 25 (42%) required 10-34 TPEs for the response. The median total plasma volume exchanged was 28 liters (range: 2.7-250 L) and the mean plasma volumes exchanged during each procedure was 3.2 (SD ± 1.09 L). The patients were classified into early responders (ER) and late responders (LR). LRs had a mean platelet count of 180 x 10 9/L by Day 5, mean LDH of 643 IU/L by Day 7, and required median of seven TPEs. ERs had a mean platelet count of 122 x 10 9/L by Day 5, mean LDH of 885 IU/L by Day 7, and required median of 19 TPEs (P = 0.001). The platelet counts were significantly higher (P = 0.01-0.03) in ERs on Days 1, 3, and 5 as compared to LRs but the LDH did not differ significantly. Seventy-seven percent of LRs had exacerbation of TTP and 18% had relapse as compared to 7% each in ERs. Thirteen patients were in coma/semicoma at presentation. Out of these, six died, making coma a bad prognostic indicator. Five of the seven survivors in coma had received two single-plasma volume exchanges on Day 1. In conclusion, 91% of TTP patients had an excellent response to plasma exchange therapy with FFP. Coma/semicoma appears to be a bad prognostic indicator. LRs needed prolonged treatment with a greater number of patients experiencing exacerbation and relapse of TTP as compared to ERs.

AB - Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the last decade who were treated with a standard therapeutic plasma exchange (TPE) protocol. Seventy percent of the patients were females. The median age of the patients was 43 years (range: 8-80). Sixty patients (85.7%) had a complete response to TPE therapy. This represented 91% of 66 who received at least one TPE. Ten patients died, two patients died before and two during the first plasma exchange. The median number of TPEs performed was nine (range: 1-85). Thirty-five (58%) out of 60 responded to 3-9 TPEs, and 25 (42%) required 10-34 TPEs for the response. The median total plasma volume exchanged was 28 liters (range: 2.7-250 L) and the mean plasma volumes exchanged during each procedure was 3.2 (SD ± 1.09 L). The patients were classified into early responders (ER) and late responders (LR). LRs had a mean platelet count of 180 x 10 9/L by Day 5, mean LDH of 643 IU/L by Day 7, and required median of seven TPEs. ERs had a mean platelet count of 122 x 10 9/L by Day 5, mean LDH of 885 IU/L by Day 7, and required median of 19 TPEs (P = 0.001). The platelet counts were significantly higher (P = 0.01-0.03) in ERs on Days 1, 3, and 5 as compared to LRs but the LDH did not differ significantly. Seventy-seven percent of LRs had exacerbation of TTP and 18% had relapse as compared to 7% each in ERs. Thirteen patients were in coma/semicoma at presentation. Out of these, six died, making coma a bad prognostic indicator. Five of the seven survivors in coma had received two single-plasma volume exchanges on Day 1. In conclusion, 91% of TTP patients had an excellent response to plasma exchange therapy with FFP. Coma/semicoma appears to be a bad prognostic indicator. LRs needed prolonged treatment with a greater number of patients experiencing exacerbation and relapse of TTP as compared to ERs.

KW - coma

KW - microangiopathic hemolytic anemia

KW - plasma exchange

KW - thrombocytopenia

KW - thrombotic thrombocytopenic purpura

UR - http://www.scopus.com/inward/record.url?scp=0031042187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031042187&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0

DO - 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0

M3 - Article

C2 - 9034283

AN - SCOPUS:0031042187

VL - 54

SP - 102

EP - 107

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -